Ezrin, a membrane-cytoskeleton linker, is required for cell morphogenesis, motility and survival through molecular mechanisms that remain to be elucidated. Using the N-terminal domain of ezrin as a bait, we found that p125 focal adhesion kinase (FAK) interacts with ezrin. We show that the two proteins coimmunoprecitate from cultured cell lysates. However, FAK does not interact with full-length ezrin in vitro, indicating that FAK binding site on ezrin is cryptic. 
-4 -actin interaction when PIP 2 is present (20, 21) . In vivo, phosphorylation of this threonine residue regulates a membrane-specific transition from inactive oligomers to active monomers (22) .
Several lines of evidence indicate that by providing linkage between the actin cytoskeleton and the plasma membrane, ERM proteins control diverse actin-based cellular functions including adhesion, morphogenesis and motility. Simultaneous inactivation of all three ERM in epithelial cells and fibroblasts by antisense oligonucleotides caused disappearance of microvilli and altered cell-cell and cell-substratum adhesion (23) . Reciprocally, overexpression of full-length ezrin in insect cells enhanced cell adhesion (17) . Selective ablation of ezrin by chromophore-assisted laser inactivation impaired membrane ruffling and motility (24) .
Overproduction of ezrin stimulates scattering and motility as well as tubulogenesis of polarized kidney-derived LLC-PK1 cells in response to hepatocyte growth factor (HGF) (18) .
Overproduction of ezrin N-terminal domain in these cells abrogated response to HGF suggesting that this domain exhibits a dominant-negative activity (18) . In addition, we recently demonstrated that ezrin also mediates survival signals through the phosphatidylinositol 3-kinase (PI 3-kinase)/Akt pathway in epithelial cells (25) .
The molecular mechanisms by which ERM proteins exhibit these diverse cellular functions are not fully understood. However, the tightly regulated ability of these proteins to interact with several targets suggests that ERM proteins function as scaffold factors by recruiting appropriate downstream effectors to specific subcellular domains. Because ERM cryptic binding -9 - NaCl, 1% NP-40, protease inhibitor cocktail, pH 7.5) for 15 min at 4°C, scraped and lysates were clarified by centrifugation at 17,000 g for 20 min at 4°C. 10 µg of either polyclonal anti-ezrin antibody or an irrelevant antibody preadsorbed on protein A Sepharose beads in presence of 2 mg/ml BSA, were incubated with 1 ml of lysate for 2 hours at 4°C. Beads were washed 4 times with 1 ml of lysis buffer and incubated for 5 min at room temperature with 40 µl of high salt RIPA buffer (50 mM Tris, 250 mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS, pH 7.5) in order to elute co-immunoprecipitated FAK.
FAK phosphorylation level in LLC-PK1 cells
Suspended cells: Subconfluent LLC-PK1 cells stably transfected with a control plasmid or a plasmid producing wild-type human ezrin were starved overnight in DMEM without CaCl 2 (DMEM*). Cells were then trypsinized, washed twice in DMEM* containing 1.5 mg/ml BSA and 50 µg/ml Soybean trypsin inhibitor (Sigma) and counted. 2.5 x10 5 cells were kept in suspension as isolated cells in DMEM* for at least 30 min before being collected by centrifugation. Adhering cells: 2.5 x10 5 suspended cells were allowed to adhere for 2 hours at 37°C to a 6-well plate coated with 100 µg of fibronectin. Fully adherent cells: Subconfluent cells grown on a 6-well plate were serum-starved overnight prior to extract preparation. When indicated, PP2 (25 µM) was added to serum-starved adherent cells 30 min before lysis and to the medium of suspended cells. Cells were lysed in Laemmli buffer and lysates were subjected to SDS-PAGE and western blot analysis with site-specific antibodies directed against FAK phosphorylated tyrosine residues.
In vitro kinase and Phosphatase assays
Kinase assay: Endogenous FAK was immunoprecipitated from COS-7 cells using the SL38 anti-serum and phosphorylation was carried out as previously described (27) except that the assay contained 10 µM ATP and 1 mM DTT and the incubation time was 30 min. When indicated, the reaction was carried out in the presence of GST-ezrin (full length: FL) or GSTEzNt (final concentration ~1 µM).
Phosphatase assay: The kinase assay was performed as described above. The reaction was stopped by the addition of EDTA to a final concentration of 14 mM. The reaction mixture was then incubated in the presence of recombinant GST, GST-EzNt (final concentration ~1 µM), or vehicle at 4°C for 10 min. Incubations were extended for 10 min at 25°C in the presence or absence of GST-PTP-β at a final concentration of ~1 µg/µl.
Reactions were stopped by the addition of Laemmli buffer and proteins separated by SDS-PAGE and transferred to nitrocellulose membranes. Western blots were performed with antibodies directed against FAK, phosphotyrosine or P-Tyr-397.
Results

Ezrin associates with the p125 focal adhesion kinase (FAK).
To further characterize the molecular mechanisms by which ezrin participates in diverse cytoskeleton-related cellular functions, we searched for ezrin-interacting proteins that may mediate and/or regulate its function. For this purpose, the N-terminal domain of ezrin fused to Glutathione S-transferase (GST-EzNt) was purified from Escherichia coli ( Figure 1A ). Affinity purification assays were then performed using immobilized GST or GST-EzNt as baits with a human placental extract because of the abundance of ezrin in this tissue (13) . Precipitated proteins were then separated by SDS-PAGE and visualized by silver staining ( Figure 1B ). Only proteins in the upper part of the gel were analyzed because of partial proteolysis of the baits during incubation with the extract. In these conditions, at least 6 candidate ezrin binding proteins were detected with sizes ranging from 75 to 165 kDa. The triplet of proteins between 75 and 83 kDa was identified as the three ERM proteins, ezrin, radixin and moesin by immunoblot analysis (data not shown). To identify the major band of 90 kDa, the pull-down assay presented in Figure   1B was scaled up 10-fold and the band was analyzed by mass fingerprinting of its derived tryptic peptides. The 90 kDa band was found to contain a mixture of at least two polypeptides. Most of the tryptic fragments matched the focal adhesion kinase (FAK), a cytoplasmic protein tyrosine kinase found at focal adhesion sites (26) . Since FAK is a 125 kDa protein, we determined whether the 90 kDa protein corresponded to a proteolytic fragment of FAK. Western blot analysis of the pull-down experiment performed with an anti-FAK antibody showed the presence of two bands: one corresponding to the full length FAK comigrating with the 125 kDa protein detected in Figure 1B and the other corresponding to the 90 kDa fragment ( Figure 1C ). We observed variable amounts of the 90 kDa band depending on the cell lysate preparation, indicating that this band corresponds to a proteolytic fragment of FAK. Neither the polypeptide comigrating with the truncated FAK nor the 165 kDa protein could be identified due to the low amount of tryptic peptides recovered.
We next examined whether full-length ezrin or its C-terminal portion (residues 280 to 585) were also able to bind to FAK in vitro. The two ezrin variants were purified from E. coli as GST fusion proteins ( Figure 1A ) and their ability to interact with FAK was analyzed in an affinity adsorption assay. Neither the C-terminal domain of ezrin nor the full-length protein were able to interact with FAK, suggesting that ezrin N-terminal binding site for FAK is cryptic in the full-length protein ( Figure 1D ). This interaction was sensitive to the salt concentration since the amount of FAK recovered with the GST-EzNt beads dropped significantly when the ionic strength of the buffer was increased to 150 mM NaCl ( Figure 1D ).
To investigate whether ezrin and FAK physically interacted in vivo, lysates from A431 epithelioid carcinoma cells were prepared. As shown in Figure 1E , FAK could be detected in the ezrin immunoprecipitate but not in a control immunoprecipitate obtained with non immune IgG.
Estimation of the amount of FAK recovered indicated that approximately 0.2% of the soluble pool of FAK coprecipitated with ezrin.
Mapping of the region of FAK interacting with ezrin.
Structurally, FAK is an atypical PTK organized in three major functional domains (26) ( Figure 2C ). FAK contains a central kinase domain followed by a C-terminal region that was found to contain a focal adhesion targeting (FAT) sequence responsible for FAK localization to focal contact sites (31) . To identify the region of FAK interacting with ezrin, the ability of truncated FAK proteins to interact with GST-EzNt was tested using affinity adsorption assays ( Figure 2A ). We found that neither FAK(693-1053) nor FAK(376-683) were able to significantly interact with GST-EzNt. However, FAK(1-376) exhibited a strong association with GST-EzNt, while a weaker interaction was observed between FAK(1-311) and GST-EzNt (Figure 2A 
Overproduction of ezrin induces FAK phosphorylation at Tyr-397 in suspended LLC-PK1 cells.
To determine whether the association of ezrin with FAK could contribute to the activation of FAK, we examined the level of FAK phosphorylation in a well characterized kidney-derived epithelial LLC-PK1 cell line overproducing VSV-G-tagged ezrin (E cells) (18) .
Using an antibody that specifically recognizes the phosphorylated residue Tyr-397, the major FAK autophosphorylation site, we estimated the level of FAK activation in serum-starved E cells and in cells transfected with an empty vector (P cells) under adherent and non adherent conditions. In suspended P cells, only residual Tyr-397 phosphorylation was detected consistent with previous observations that FAK becomes phosphorylated on Tyr-397 in response to cell adhesion (reviewed in (32) ). Surprisingly, a significantly higher phosphorylation level of the Tyr-397 residue was detected in suspended E cells ( Figure 3A, sus) . Three independent E clones were analyzed, and a good correlation was observed between the amount of ezrin present in the cells and the level of FAK phosphorylation on Tyr-397 ( Figure 3B) . The FAK phosphorylation level remained higher in E cells than in P cells at least 2 hours after adhesion on fibronectin had started ( Figure 3A, adh) . However, the effect of ezrin overproduction on FAK phosphorylation became negligible in cells that had been allowed to adhere overnight (data not shown). Thus, in suspended cells, overproduction of ezrin induced FAK phosphorylation through a mechanism that does not require adhesion of the cells to matrix proteins nor serum stimulation. However, ezrin did not significantly contribute to FAK Tyr-397-phosphorylation in fully adherent cells.
In vitro kinase assay with immunoprecipitated FAK
To get insight into the mechanism of the ezrin-induced FAK phosphorylation observed in LLCPK-1 cells, we performed an in vitro kinase assay with immunoprecipitated FAK in presence of various ezrin constructs. We found that neither the full-length protein nor the Nterminal domain of ezrin could stimulate the autophosphorylation activity of immunoprecipitated FAK ( Figure 4A ). We next examined whether ezrin could prevent FAK dephosphorylation rather than induce its phosphorylation. For this, we determined the ability of GST-EzNt to protect FAK from dephosphorylation by PTP-β phosphatase in vitro. As shown in Figure 4B , the tyrosine phosphatase dephosphorylated efficiently the residue Tyr-397, and its action was not altered by the presence of either GST or GST-EzNt. Thus, the activation of FAK cannot be simply the effect of the binding of ezrin N-ter domain to FAK. (33, 34) . To determine whether the Src kinases were involved in ezrin-mediated FAK phosphorylation, we examined the level of phosphorylation of the Tyr-577 residue using a phosphospecific anti-Tyr-577 antibody. We observed an increase in the phosphorylation of this residue in suspended E cells compared to control P cells ( Figure 5A ). Treatment of suspended E cells with PP2, a Src kinase inhibitor, abrogated Tyr-577 phosphorylation confirming the requirement for Src kinases in Tyr-577 phosphorylation ( Figure 5B ). However, in suspended E cells treated with PP2, the level of Tyr-397-phosphorylation remained high while in adherent E cells treated with PP2, phosphorylation of Tyr-397 was reduced. This indicated that Src kinases are not required for adhesionindependent FAK Tyr-397 phosphorylation mediated by overproduction of ezrin ( Figure 5B ).
Moreover, we constantly observed a slightly higher level of FAK phosphorylation on Tyr-397 in PP2-treated than in non-treated cells kept in suspension.
Discussion
Ezrin, a membrane-cytoskeleton linker, has been implicated in diverse cellular processes such as determination of cell shape, cell adhesion, motility and survival. Although a number of ezrin partners have been identified to date, the mechanisms by which ezrin exerts its functions are still unclear suggesting that other effectors of ezrin remain to be identified. We report here the identification of a novel partner of ezrin, p125 focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase also involved in cell motility and survival. Moreover, we show that when overproduced in LLC-PK1 cells, ezrin triggers FAK activation independently of cell matrix adhesion and growth factor stimulation. This observation suggests that ezrin can promote FAK activation through a mechanism that does not require activation of the cell by external stimuli. anchorage-independent growth of these cells (44) . Reciprocally, attenuation of FAK expression leads to apoptosis in tumors cells (45) . In addition, it was shown that FAK can regulate the PI 3-kinase/Akt survival pathway (46-48). It is therefore possible that ezrin-mediated FAK activation contributes to cell survival in non-adherent conditions. Indeed, we previously established that ezrin phosphorylated on Tyr-353, one of the major sites of phosphorylation by the EGF receptor (49), transduces a survival signal through the PI 3-kinase/Akt pathway in LLC-PK1 cells (25) .
Thus, it is conceivable that in normal epithelial cells, ezrin membrane recruitment regulates the activity of the FAK/PI 3-kinase/Akt survival pathway. 
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